Aslan Pharmaceuticals
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- -
- Employees
- 35
- Market Cap
- $1.6M
- Introduction
ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for...
Global Molybdenum Cofactor Deficiency Type-A (MoCoD-A) Treatment Market
The global MoCoD-A treatment market, valued at USD 25 million in 2022, is projected to reach USD 89.96 million by 2033, driven by advancements in genetic and precision medicine. Key players include BridgeBio Pharma, Origin Biosciences, and Orphatech Pharmaceuticals, with treatments like BBP-871 for MoCoD-A. The market growth emphasizes the need for continued research in rare genetic diseases.
Clinical Trial Supplies Market Growth Analysis | CAGR of 7.5%
Global Clinical Trial Supplies Market expected to grow from US$ 3.1 billion in 2023 to US$ 6.4 billion by 2033, driven by complex diseases, innovative therapies, and advanced technologies like decentralized clinical trials (DCTs). Key market segments include Phase III trials, supply chain management, pharma & biotech companies, and oncology. North America leads with a 40.1% share, while Asia Pacific shows the highest growth.
© Copyright 2024. All Rights Reserved by MedPath